Antlion (Myrmeleon sp.) Infusion as Antidiabetic in Dexamethasone Induced Mice

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diabetes Mellitus (DM) is a degenerative disease which classified as number 6 death caused worldwide mark by hyperglycemia condition. Antlion (Myrmeleon sp.) used as antidiabetic traditionally in Tasikmalaya. This research aims to evaluate antlion (Myrmeleon sp.) infusion antidiabetic activity. Dexamethasone was used to induce hyperglycemia condition in all treatment group. Negative group were given CMC 0,5%, positive group were given metformin 1,3 mg/20 g bw, dose 1, dose 2 and dose 3 were given antlion infusion 0,104 mg/20 g bw, 0,208 mg/20 g bw and 0,416 mg/20 g bw respectively. The effect of antlion infusion was observed at 0, 30, 60, 90 and 120 minutes. Antlion infusion has an antidiabetic activity which dose 2 showed the best effect in decreasing blood glucose. The best blood glucose decreasement (BGC) come out from dose 2 with % BGC at 60, 90 and 120 minutes 28,19%, 28,39 %, and 31,20 % respectively.

Cite

CITATION STYLE

APA

Maryati, Y., Alifiar, I., Nurfatwa, M., Nofianti, T., & Rahayuningsih, N. (2019). Antlion (Myrmeleon sp.) Infusion as Antidiabetic in Dexamethasone Induced Mice. In Journal of Physics: Conference Series (Vol. 1179). Institute of Physics Publishing. https://doi.org/10.1088/1742-6596/1179/1/012177

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free